Controlling Dengue in times of Pandemic by COVID-19
Keywords:
dengue, epidemiological control, covid 19Abstract
Jorge Osorio, DVM, PhD works in Pathology Biology at the University of Wisconsin in the USA. His research team uses a molecular approach to understand interactions between host-pathogen for emerging diseases (West Nile, dengue) and biodefense pathogens (Plague, MonkeyPox). Research novel human vaccines like Dengue, Chikungunya, and Plague. We invite you to reflect on your experience in developing a dengue vaccine.
Downloads
Download data is not yet available.
References
1. https://www.paho.org/data/index.php/en/mnutopics/, indicadores-dengue-en/dengue-nacional-en/252-dengue-pais-ano-en.html. Accessed.
2. Sharma A. It is too soon to attribute ADE to COVID-19. Microbes and infection / Institut Pasteur. 2020.
3. Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020;81:104260.
4. Halstead SB. Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine. Hum Vaccin Immunother. 2018;14(9):2158-2162.
5. O'Neill SL. The Use of Wolbachia by the World Mosquito Program to Interrupt Transmission of Aedes aegypti Transmitted Viruses. Adv Exp Med Biol. 2018;1062:355-360.
2. Sharma A. It is too soon to attribute ADE to COVID-19. Microbes and infection / Institut Pasteur. 2020.
3. Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020;81:104260.
4. Halstead SB. Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine. Hum Vaccin Immunother. 2018;14(9):2158-2162.
5. O'Neill SL. The Use of Wolbachia by the World Mosquito Program to Interrupt Transmission of Aedes aegypti Transmitted Viruses. Adv Exp Med Biol. 2018;1062:355-360.
Published
2020-07-31
How to Cite
1.
Osorio J. Controlling Dengue in times of Pandemic by COVID-19. PFR [Internet]. 2020Jul.31 [cited 2025Dec.14];5(2). Available from: https://practicafamiliarrural.org/index.php/pfr/article/view/162
Issue
Section
Cartas al editor
